Access History Research and Development 
Cannabis Law Report
AUGUST 10, 2021
As psychedelic therapy trials approach FDA approval, researchers express the urgent need to ensure effectiveness and accessibility to communities of color. Madison Natarajan, MS. – August 5, 2021.
NORML
MARCH 7, 2019
In the previous Congress, The Ending Federal Marijuana Prohibition Act became the first bill in American history to end the federal policy of criminalization that earned bipartisan support. They have stimulated economic development and created hundreds of millions of dollars in new tax revenue.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Project CBD
NOVEMBER 11, 2023
NM: As someone who has been researching cannabis for decades, how do you feel about the current legalization situation worldwide and in Japan, in particular? Dr. Andrew Weil: I think the trend very clearly is that in most developed countries, cannabis is being made legal first for medical uses and then also for recreational uses.
Veriheal
MARCH 17, 2022
However, new research has found that psychedelic use is only “weakly associated with psychosis-like symptoms.” New Research Published on Serotonergic Psychedelic Use and Psychosis. New Research Published on Serotonergic Psychedelic Use and Psychosis. The research team under the leadership of Alexander V.
Cannabis Law Report
JULY 28, 2021
This direct access to patients and clinics is expected to differentiate KGK from other CROs by providing the opportunity to study patients with differing demographics across various populations, while also shortening recruitment timelines for studies.
MMJ Recs
FEBRUARY 10, 2024
This article explores the history of medical marijuana in Ohio, analyzes the changing attitudes and acceptance, and delves into the impact of stigma on its journey to legalization. Scientific research, patient testimonials, and a broader understanding of the plant’s medicinal properties have fundamentally altered public views.
Cannabis Law Report
SEPTEMBER 8, 2021
Key Transaction Details: The Valens Company, a leading Canadian manufacturer of cannabis products, has entered into a long-term partnership with Epsilon, for exclusive access to the Epsilon’s GMP Manufacturing Facility in Southport , Queensland Australia (the “ Southport Facility ‘).
Expert insights. Personalized for you.
105 
Let's personalize your content